↓ Skip to main content

Operative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer: Single-Institution Analysis of Breast Conservation with Oncoplastic Reconstruction

Overview of attention for article published in Annals of Surgical Oncology, July 2016
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
130 Dimensions

Readers on

mendeley
65 Mendeley
Title
Operative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer: Single-Institution Analysis of Breast Conservation with Oncoplastic Reconstruction
Published in
Annals of Surgical Oncology, July 2016
DOI 10.1245/s10434-016-5407-9
Pubmed ID
Authors

Stacey A. Carter, Genevieve R. Lyons, Henry M. Kuerer, Roland L. Bassett, Scott Oates, Alastair Thompson, Abigail S. Caudle, Elizabeth A. Mittendorf, Isabelle Bedrosian, Anthony Lucci, Sarah M. DeSnyder, Gildy Babiera, Min Yi, Donald P. Baumann, Mark W. Clemens, Patrick B. Garvey, Kelly K. Hunt, Rosa F. Hwang

Abstract

Oncoplastic reconstruction is an approach that enables patients with locally advanced or adversely located tumors to undergo breast conserving surgery (BCS). The objectives were to identify the use of BCS with oncoplastic reconstruction (BCS + R) and determine the operative and oncologic outcomes compared with other breast surgical procedures for breast cancer. This retrospective cohort study interrogated a single institution's prospectively maintained databases to identify patients who underwent surgery for breast cancer between 2007 and 2014. Surgeries were categorized as BCS, BCS + R, total mastectomy (TM), or TM with immediate reconstruction (TM + R). Demographic and clinicopathologic characteristics and postoperative complications were analyzed. There were 10,607 operations performed for 9861 patients. Median follow-up was 3.4 years (range, 0-9.1 years). The use of BCS + R had a nearly fourfold increase in the percentage of all breast cancer surgeries during the study period; 75 % of patients who underwent BCS + R had a T1 or T2 tumor. There was no difference in the use of BCS + R compared with BCS for any quadrant of the breast except the lower outer quadrant (11.1 vs. 6.8 %; p < .0001). BCS + R had a lower rate of seroma formation (13.4 vs. 18 %; p = .002) and positive or close margins compared with BCS (5.8 vs. 8.3 %; p = .04). There was no difference in overall survival or recurrence-free survival when comparing BCS and BCS + R. Patients undergoing BCS + R are not disadvantaged in terms of complications and short-term (3-year) outcomes compared with BCS patients or patients who underwent TM.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 65 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 15%
Other 6 9%
Student > Ph. D. Student 6 9%
Student > Master 6 9%
Student > Bachelor 5 8%
Other 14 22%
Unknown 18 28%
Readers by discipline Count As %
Medicine and Dentistry 37 57%
Biochemistry, Genetics and Molecular Biology 2 3%
Chemistry 2 3%
Environmental Science 1 2%
Business, Management and Accounting 1 2%
Other 4 6%
Unknown 18 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 July 2016.
All research outputs
#20,705,128
of 23,305,591 outputs
Outputs from Annals of Surgical Oncology
#5,606
of 6,608 outputs
Outputs of similar age
#310,273
of 356,095 outputs
Outputs of similar age from Annals of Surgical Oncology
#146
of 168 outputs
Altmetric has tracked 23,305,591 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,608 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 356,095 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 168 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.